美国食品和药物管理局突破性治疗指标 减少晚期药物开发时间
Kathleen L Miller1, Ariel D Stern2, Aaron Kearsley3
1Kathleen L. Miller (kathleen.miller@hhs.gov), Department of Health and Human Services, Washington, D.C.
Health affairs (Project Hope)
|July 1, 2024
概括
美国食品和药物管理局 (FDA) 的突破性治疗指标 (BTD) 计划加速了药物开发. 这项分析表明,BTD药物在临床试验的后期阶段花费的时间减少了30%,改善了患者获得新疗法的机会.
科学领域:
- 监管科学 监管科学
- 制药发展 制药发展
- 临床试验 临床试验
背景情况:
- 美国食品和药物管理局的突破性治疗指标 (BTD) 计划旨在加速患者获得创新的治疗方法.
- 有效的临床开发对于为患者提供安全有效的疗法至关重要.
研究的目的:
- 评估FDA的BTD计划对晚期临床开发持续时间的影响.
- 量化BTD对从第二阶段末期会议到营销批准的时间的影响.
主要方法:
- 对2006年至2020年间批准的药物的关键发展里程碑数据集的分析.
- 对BTD指定药物的开发时间表进行比较,与FDA专家确定的一组对照药物进行比较.
主要成果:
- 经过BTD计划,临床开发的后期阶段的时间减少了30%.
- 这表明BTD指定疗法药物批准过程的显著加速.
结论:
- 美国食品和药物管理局的BTD计划有效地缩短了晚期临床开发时间表.
- 这些发现支持了旨在提高医疗产品开发效率和及时患者获取医疗产品的监管和创新政策.
更多相关视频
相关概念视频
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Drug Administration and Therapy Phases: Overview
446
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
446
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K


